Oppenheimer reiterates a Perform rating on Cartesian Therapeutics (RNAC) without a price target following the company’s Q4 report. The ...

Amgen (AMGN) announced new data from the Phase 3, registrational MINT trial evaluating the efficacy and safety of Uplinza in adults living with ...

Most organizations have some type of multifunctional committee set up to evaluate generative AI applications. Those ...

Most organizations have some type of multi-functional committee set up to evaluate generative AI applications. Those ...

A study in people with obesity and diabetes again found CagriSema helps people lose weight, but not by enough to clearly ...

36,718 people played the daily Crossword recently. Can you solve it faster than others?36,718 people played the daily Crossword recently. Can you solve it faster than others?

In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against the other undervalued stocks. On March 5th, BBC reported that the US stock market had fallen after the ...

MariTide is a monthly injection that investors hope could compete against existing weight loss drugs from Novo Nordisk and ...

Amgen (AMGN) is getting closer to challenging the weight-loss drug duopoly of Novo Nordisk (NVO), the maker of Ozempic and ...

Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world’s toughest diseases. More than 40 years ago, Amgen ...